Pharmaceutical News 2022/06/24 National Taiwan University Hospital report NT$1 billion loss in 2021 Read More 2022/06/25 TFDA orders manufacturer to recall Rixia due to low API content Read More 2022/06/19 Doctors urge the BNHI to relax the reimbursement regulations for diabetes drugs Read More 2022/06/17 Biotech tax incentive to see lowered requirements Read More 2022/06/12 Hurdles to remote consultation stagnate the prescription rate of antiviral drugs Read More 2022/06/03 MOEA drafts tax incentives for biotech companies’ investment in machinery Read More 2022/05/27 Taiwan cannot be a healthcare superpower without a viable biotechnology sector Read More 2022/05/28 Using pharmacoeconomics to improve the benefits of healthy life expectancy Read More 2022/05/20 Taiwan cannot be a healthcare superpower without a viable biotechnology sector Read More 2022/05/21 NHIA conditionally expands the reimbursement scope of biosimilars Read More 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 Page 1Page 2Page 3Page 4Page 5Page 6Page 7Page 8Page 9Page 10Page 11Page 12Page 13Page 14Page 15Page 16Page 17Page 18Page 19Page 20Page 21Page 22Page 23Page 24Page 25Page 26Page 27Page 28Page 29Page 30Page 31Page 32Page 33Page 34Page 35Page 36Page 37Page 38Page 39Page 40Page 41Page 42Page 43Page 44Page 45Page 46Page 47Page 48Page 49Page 50Page 51Page 52Page 53Page 54Page 55Page 56Page 57Page 58Page 59Page 60Page 61Page 62Page 63Page 64Page 65Page 66Page 67Page 68Page 69Page 70Page 71Page 72Page 73Page 74Page 75Page 76Page 77
2022/06/24 National Taiwan University Hospital report NT$1 billion loss in 2021 Read More 2022/06/25 TFDA orders manufacturer to recall Rixia due to low API content Read More 2022/06/19 Doctors urge the BNHI to relax the reimbursement regulations for diabetes drugs Read More 2022/06/17 Biotech tax incentive to see lowered requirements Read More 2022/06/12 Hurdles to remote consultation stagnate the prescription rate of antiviral drugs Read More 2022/06/03 MOEA drafts tax incentives for biotech companies’ investment in machinery Read More 2022/05/27 Taiwan cannot be a healthcare superpower without a viable biotechnology sector Read More 2022/05/28 Using pharmacoeconomics to improve the benefits of healthy life expectancy Read More 2022/05/20 Taiwan cannot be a healthcare superpower without a viable biotechnology sector Read More 2022/05/21 NHIA conditionally expands the reimbursement scope of biosimilars Read More
